Analysts expect Suja Life to report Q1 2026 revenue of $248.5 million and EPS of $0.18, with the current share price of $24.80 trailing the average analyst price target of $32.00.
The primary story for investors is the company’s gross margin performance as it scales its proprietary High Pressure Processing (HPP) technology.
Suja has seen significant volume growth in the functional wellness category, driven by its recent expansion into the energy shot and probiotic juice segments. Market participants will be looking for evidence that the company can sustain its premium pricing power in a competitive beverage landscape dominated by larger conglomerates.